North America Memory Supplement Market Size, Share and Growth Analysis Report - Forecast Trends and Outlook 2026-2030

Memory supplements occupy a high-growth niche within the broader North American dietary supplements market, which is projected to reach $91.3 billion across the region by 2030. The memory and brain-health sub-segment alone was valued at roughly $10.5 billion globally in 2026, with North America accounting for an estimated 39% share, making it the single largest regional market. Products span single-ingredient botanical capsules to clinically dosed multi-stack formulations designed to support recall, focus, and overall cognitive performance.

• •Global brain health supplement market valued at $10.48 billion in 2026, growing at 10.8% CAGR through 2035
• •North America holds approximately 39% of global brain health supplement revenue
• •Capsules remain the dominant product format, with gummies and chewables the fastest-growing delivery mode

The aging of the North American population is the primary structural driver: the Alzheimer's Association reported roughly 6.9 million Americans aged 65 and older living with Alzheimer's disease in 2024, creating a large and growing consumer base seeking preventive cognitive support. Public-sector investment has dramatically accelerated, with the U.S. National Institutes of Health allocating $3.7 billion to neuroscience research in fiscal year 2024, generating ingredient-efficacy data that manufacturers increasingly cite on product labels.

• •Approximately 6.9 million Americans aged 65+ living with Alzheimer's disease as of 2024, per the Alzheimer's Association
• •NIH allocated $3.7 billion to neuroscience research in fiscal year 2024, fueling new ingredient-evaluation pipelines
• •National health agencies across the EU committed over EUR 1.2 billion to dementia-prevention research through 2030, reinforcing global R&D momentum

Within the North American market, the United States dominates, accounting for an estimated 72.1% of regional market share in 2025. By product type, vitamins and botanicals are the leading categories, while capsules remain the preferred delivery format. Growing consumer preference for plant-based and clean-label products is reshaping formulation priorities across all cognitive-health categories.

• •The United States represents approximately 72.1% of the North American dietary supplements market by country share
• •Vitamins segment expected to register a significant CAGR of 8.2% within the broader supplements category
• •Plant-based and clean-label formulations are increasingly driving purchasing decisions

Who are the notable companies in the industry?

The North American memory supplement market features a moderately fragmented competitive structure, with a mix of large diversified consumer-health companies and a substantial population of mid-sized specialty producers focused exclusively on nootropic and cognitive-support formulations. The supply chain spans vertically integrated operators controlling full production from raw-material sourcing through finished-goods manufacturing, as well as specialty firms that outsource compounding while focusing on formulation science and brand marketing.

• •Production is concentrated among a mix of large diversified consumer-health conglomerates and mid-sized specialty nootropic formulators, yielding moderate market fragmentation
• •Key technology routes include conventional dry-blend encapsulation, liposomal delivery systems, and cyclodextrin complexation to enhance bioavailability of botanical and synthetic actives
• •Manufacturing and sourcing capacity is heavily concentrated in the United States, with the country serving as the primary domestic production and export hub for the region

What are the recent trends and outlook?

Conventional single-ingredient capsules are giving way to clinically dosed, multi-stack blends that pair botanical actives with bioavailability-enhancing delivery technologies such as liposomal encapsulation and cyclodextrin complexation. Regulatory scrutiny around health claims is intensifying, pushing manufacturers toward science-backed labeling derived from the growing body of NIH-funded clinical research. The market is expected to sustain its 10.8% CAGR through 2035 as cognitive health transitions from a niche wellness concern to a mainstream preventive-health priority.

• •Multi-ingredient nootropic stacks with liposomal or cyclodextrin delivery systems are displacing traditional single-ingredient capsules
• •Increasing regulatory attention to supplement labeling claims is driving greater reliance on NIH-funded clinical data for product substantiation
• •Projected to reach $26.38 billion globally by 2035, with North America retaining its position as the dominant regional market